Information  X 
Enter a valid email address

ThromboGenics NV (0G99)

  Print   

Thursday 28 September, 2017

ThromboGenics NV

ThromboGenics NV : ThromboGenics Successfully Introduces New 'Already-Diluted' Formulation of JETREA® (ocriplasmin) in the US

YASTEST

a d v e r t i s e m e n t